Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-19

Clinical Trial Update: NGS Panel of Incomplete Forms of Ocular Albinism

View source ↗

Summary

The clinical trial evaluating a next-generation sequencing panel for incomplete forms of ocular albinism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Bordeaux | Conditions: Albinism, Ocular | Status: COMPLETED